Results 81 to 90 of about 1,080 (176)

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease. [PDF]

J Comp Eff Res
Parsekar K, Pandey S, Tansey-Dwyer D, Marshall J, Rustignoli I, Pollack M, Singh B, Ouwens M.   +7 more
europepmc   +1 more source

Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography. [PDF]

Medicina (Kaunas)
Shin HJ, Koo BW, Kim JN, Park JI, Na HS.
europepmc   +1 more source

The Effect of Maropitant, Ondansetron and Metoclopramide on Dexmedetomidine-Induced Vomiting in Cats. [PDF]

Vet Med Sci
Gölgeli Bedir A, Yanmaz LE, Okur S, Şenocak MG, Turgut F, Kocaman Y, Orhun ÖT, Ersöz U, Baykal B.   +8 more
europepmc   +1 more source

Program of Section Meetings and Table of Contents [PDF]

, 1950

core   +1 more source

Pharmacokinetics, safety, and efficacy of mixed formulation of fosrolapitant and palonosetron (HR20013) in combination with dexamethasone in patients with solid tumors scheduled for highly emetogenic cisplatin-based chemotherapy: a phase I trial. [PDF]

BMC Med
Zhao Y, Ma Y, Yin T, Qin Z, Liu L, Kong G, Zhang R, Huang Y, Zhang L, Zhao H.   +9 more
europepmc   +1 more source

Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial. [PDF]

Oncologist
Liu X, Meng Y, Du Y, Mu Y, Li G, Li H, Guan X, Zhang J.   +7 more
europepmc   +1 more source

Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL. [PDF]

Int J Chron Obstruct Pulmon Dis
Sethi S, Clark B, Buysman EK, Sargent A, Bengtson LGS.   +4 more
europepmc   +1 more source

Establishing the Median and 95% Effective Doses of Oliceridine for Immediate Post-Surgical Analgesia Following Laparoscopic Cholecystectomy: A Double-Blind, Sequential Dose-Finding Study. [PDF]

Drug Des Devel Ther
Cao X, Xiao H, Yan H, Wei Y, Wen Q, Zhang Z, Xu G, Xu B, Chen J, Li X.   +9 more
europepmc   +1 more source

Real-World Safety and Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Asthma: Final Analysis of a Post-Marketing Surveillance in Japan. [PDF]

Adv Ther
Asai K, Morioka Y, Ito R, Komatsubara M, Maruoka H.   +4 more
europepmc   +1 more source